mTOR inhibitors in advanced renal cell carcinoma - Abstract - UroToday PDF Print
UroToday
Better understanding of the molecular biology of renal cell carcinoma (RCC) has led to the development of several targeted anti-cancer agents, several of which have since received approval for treatment of advanced disease.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.